Anti-amyloidogenic agents

A method for treating a human amyloid disease which includes administering a pharmaceutically effective amount of a composition including an amyloidogenic protein-stabilizing aryl compound


Year:
1998
Note:
Applicant(s): Texas A & M Univ Sys [Us], Miroy G. J., Kelly J. W., Lai Z., Lashuel H. A., Peterson S. A.
Other identifiers:
EPO Family ID: 25093393
Patent number(s):
Laboratories:




 Record created 2009-10-29, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)